TRINETRA › Sectors › Metals & Mining
Morepen Laboratories Limited (MOREPENLAB) — share price, P/E and fundamentals
Morepen Laboratories Limited (NSE: MOREPENLAB) closed at ₹113.35 on 30 Oct 2026, +135.7% over one year, against a 52-week range of ₹33.05 – ₹150.70.
In the quarter ended 30 Sept 2026 (consolidated, filed 27 Oct 2026) it reported revenue of ₹747 cr and net profit of ₹89 cr, a 11.9% net margin; revenue grew 81.4% and profit grew 155.0% year on year.
On four consecutive filed quarters its trailing P/E is 32.9; since 12 May 2025 its own P/E has ranged from 15.4 to 57.4 (median 24.4), and today's reading is higher than 82% of those 364 trading days.
From the balance sheet dated 30 Sept 2026: return on equity 25.8%, ROCE 30.8%, debt-to-equity 0.22, Piotroski F-score 5 of 9.
Against 27 Metals & Mining peers on NSE: Net margin higher than 56% of 27 sector peers; PBT margin higher than 52% of 27 sector peers; ROE higher than 67% of 27 sector peers.
Key figures
| Last close | ₹113.35 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -2.8% / +171.7% / +135.7% |
| 52-week low – high | ₹33.05 – ₹150.70 |
| Market capitalisation | ₹6,211 cr |
| Trailing P/E | 32.9 |
| Price / book | 4.50 |
| EV / EBITDA | 21.0 |
| Earnings yield | 3.0% |
| TTM EPS | ₹3.44 |
| TTM net profit | ₹189 cr |
| Quarter revenue | ₹747 cr |
| Quarter net profit | ₹89 cr |
| Net margin | 11.9% |
| Revenue growth (YoY) | +81.4% |
| Profit growth (YoY) | +155.0% |
| Return on equity | 25.8% |
| ROCE | 30.8% |
| Debt / equity | 0.22 |
| Current ratio | 1.98 |
| Free cash flow | ₹63 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹198.8 cr |
Against Metals & Mining peers
| Metric | MOREPENLAB | Peer median | Percentile |
|---|---|---|---|
| Net margin | 11.91 | 9.69 | 56 |
| PBT margin | 15.61 | 12.41 | 52 |
| ROE | 25.75 | 17.80 | 67 |
| ROCE | 30.82 | 19.98 | 70 |
| Debt / equity | 0.22 | 0.34 | 33 |
| FCF margin | 4.76 | 6.54 | 46 |
| Cash conversion | 0.88 | 1.11 | 36 |
| Trailing P/E | 32.94 | 17.43 | 77 |
Questions
What is the P/E ratio of Morepen Laboratories Limited?
Morepen Laboratories Limited's trailing P/E is 32.9, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 12 May 2025 its P/E has ranged 15.4–57.4.
What were Morepen Laboratories Limited's latest quarterly results?
For the quarter ended 30 Sept 2026, Morepen Laboratories Limited reported revenue of ₹747 cr and net profit of ₹89 cr (consolidated), filed with the exchange on 27 Oct 2026.
What is Morepen Laboratories Limited's ROE?
Return on equity is 25.8% based on the balance sheet dated 30 Sept 2026.
Does Morepen Laboratories Limited have debt?
Debt-to-equity is 0.22 on the balance sheet dated 30 Sept 2026.
What is MOREPENLAB's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, MOREPENLAB traded between ₹33.05 and ₹150.70.
Other Metals & Mining stocks
- Adani Enterprises Limited (ADANIENT)
- Hindustan Zinc Limited (HINDZINC)
- Tata Steel Limited (TATASTEEL)
- Hindalco Industries Limited (HINDALCO)
- Vedanta Aluminium Metal Limited (VAML)
- JINDAL STEEL LIMITED (JINDALSTEL)
- Lloyds Metals And Energy Limited (LLOYDSME)
- Vedanta Limited (VEDL)
- Steel Authority of India Limited (SAIL)
- NMDC Limited (NMDC)
- National Aluminium Company Limited (NATIONALUM)
- Jindal Stainless Limited (JSL)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Sept 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.